Abstract
Inflammation, a localized response to tissue injury, and disorders characterized by inflammation are difficult problems in clinical medicine. This difficulty stems in large part from incomplete understanding of inflammatory processes and their regulation. Recent development of knowledge of the role of central nervous system and neuroendocrine system in host responses has provided a new view of the capacity of neuronal and soluble mediators in these systems to influence inflammation. One of these mediators is the endogenous neuropeptide α-melanocyte stimulating hormone (α-MSH), which is an N-acetyl tridecapeptide derived from the cleavage of a larger precursor molecule, pro-opiomelanocortin (POMC). α-MSH is widely distributed in tissues of higher organisms, it has been identified in the pituitary, various brain regions, skin, circulation and other sites. The neuropeptide α-MSH is important to the natural limitation of fever, which is an early host response to endotoxin. In addition to its action within the brain to reduce fever, α-MSH has potent and broad antiinflammatory effects in many forms of inflammation. This review will summarize the data on the actions of the peptide on various aspects of peripheral and central inflammation. On the basis of the data presented, we may think that the antiinflammatory actions of the peptide via peripheral and / or central melanocortin receptors might put the peptide into practice therapeutically in near future.
Keywords: Melanocyte, BRAIN INFLAMMATION
Current Protein & Peptide Science
Title: Modulation of the Peripheral and Central Inflammatory Responses by a-Melanocyte Stimulating Hormone
Volume: 3 Issue: 6
Author(s): B. K. Oktar and I. Alican
Affiliation:
Keywords: Melanocyte, BRAIN INFLAMMATION
Abstract: Inflammation, a localized response to tissue injury, and disorders characterized by inflammation are difficult problems in clinical medicine. This difficulty stems in large part from incomplete understanding of inflammatory processes and their regulation. Recent development of knowledge of the role of central nervous system and neuroendocrine system in host responses has provided a new view of the capacity of neuronal and soluble mediators in these systems to influence inflammation. One of these mediators is the endogenous neuropeptide α-melanocyte stimulating hormone (α-MSH), which is an N-acetyl tridecapeptide derived from the cleavage of a larger precursor molecule, pro-opiomelanocortin (POMC). α-MSH is widely distributed in tissues of higher organisms, it has been identified in the pituitary, various brain regions, skin, circulation and other sites. The neuropeptide α-MSH is important to the natural limitation of fever, which is an early host response to endotoxin. In addition to its action within the brain to reduce fever, α-MSH has potent and broad antiinflammatory effects in many forms of inflammation. This review will summarize the data on the actions of the peptide on various aspects of peripheral and central inflammation. On the basis of the data presented, we may think that the antiinflammatory actions of the peptide via peripheral and / or central melanocortin receptors might put the peptide into practice therapeutically in near future.
Export Options
About this article
Cite this article as:
Oktar K. B. and Alican I., Modulation of the Peripheral and Central Inflammatory Responses by a-Melanocyte Stimulating Hormone, Current Protein & Peptide Science 2002; 3 (6) . https://dx.doi.org/10.2174/1389203023380396
DOI https://dx.doi.org/10.2174/1389203023380396 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
Call for Papers in Thematic Issues
Advancements in Proteomic and Peptidomic Approaches in Cancer Immunotherapy: Unveiling the Immune Microenvironment
The scope of this thematic issue centers on the integration of proteomic and peptidomic technologies into the field of cancer immunotherapy, with a particular emphasis on exploring the tumor immune microenvironment. This issue aims to gather contributions that illustrate the application of these advanced methodologies in unveiling the complex interplay ...read more
Artificial Intelligence for Protein Research
Protein research, essential for understanding biological processes and creating therapeutics, faces challenges due to the intricate nature of protein structures and functions. Traditional methods are limited in exploring the vast protein sequence space efficiently. Artificial intelligence (AI) and machine learning (ML) offer promising solutions by improving predictions and speeding up ...read more
Nutrition and Metabolism in Musculoskeletal Diseases
The musculoskeletal system consists mainly of cartilage, bone, muscles, tendons, connective tissue and ligaments. Balanced metabolism is of vital importance for the homeostasis of the musculoskeletal system. A series of musculoskeletal diseases (for example, sarcopenia, osteoporosis) are resulted from the dysregulated metabolism of the musculoskeletal system. Furthermore, metabolic diseases (such ...read more
Protein Folding, Aggregation and Liquid-Liquid Phase Separation
Protein folding, misfolding and aggregation remain one of the main problems of interdisciplinary science not only because many questions are still open, but also because they are important from the point of view of practical application. Protein aggregation and formation of fibrillar structures, for example, is a hallmark of a ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick
Mini-Reviews in Medicinal Chemistry Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation
Current Cancer Drug Targets Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Lipid Metabolism and Mitochondria: Cross Talk in Cancer
Current Drug Targets Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective
Current Medicinal Chemistry On the Epistemological Crisis in Genomics
Current Genomics Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets β-Lactams as Neuroprotective Agents
Anti-Infective Agents in Medicinal Chemistry PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders
Current Drug Delivery Meet Our Editorial Board Member
Recent Patents on Inflammation & Allergy Drug Discovery Targeting Focal Adhesion Kinase in Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and Prevention
Current Protein & Peptide Science Influence of Polymer Molecular Weight on in-vitro Characteristics and Cytotoxicity of Fulvestrant Loaded Nanoparticles
Current Drug Therapy Review of Noscapine and its Analogues as Potential Anti-Cancer Drugs
Mini-Reviews in Organic Chemistry Exercise-Induced Overexpression of Angiogenic Factors and Reduction of Ischemia / Reperfusion Injury in Stroke
Current Neurovascular Research Resveratrol Counteracts Hypoxia-Induced Gastric Cancer Invasion and EMT through Hedgehog Pathway Suppression
Anti-Cancer Agents in Medicinal Chemistry From Protein to Peptides: a Spectrum of Non-Hydrolytic Functions of Acetylcholinesterase
Protein & Peptide Letters EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Metastatic Behaviour Modulation
Current Gene Therapy Role of Epigenetics and Oxidative Stress in Gliomagenesis
CNS & Neurological Disorders - Drug Targets